vs

Side-by-side financial comparison of Clearwater Paper Corp (CLW) and HCW Biologics Inc. (HCWB). Click either name above to swap in a different company.

HCW Biologics Inc. is the larger business by last-quarter revenue ($394.8K vs $360.3K, roughly 1.1× Clearwater Paper Corp). Clearwater Paper Corp runs the higher net margin — -3.6% vs -854.4%, a 850.9% gap on every dollar of revenue. On growth, Clearwater Paper Corp posted the faster year-over-year revenue change (-4.7% vs -70.2%). Over the past eight quarters, HCW Biologics Inc.'s revenue compounded faster (-45.8% CAGR vs -96.8%).

Clearwater Paper Corporation is an American pulp and paperboard manufacturer. The company was created on December 9, 2008, via a spin-off from Potlatch Corporation and is headquartered in Spokane, Washington.

HCW Biologics Inc. is a clinical-stage biotechnology company focused on researching and developing novel immunotherapies and biological products targeting unmet medical needs in oncology, chronic inflammatory disorders, and autoimmune diseases. It primarily operates in the U.S., advancing multiple pipeline candidates through early to mid-stage clinical trials.

CLW vs HCWB — Head-to-Head

Bigger by revenue
HCWB
HCWB
1.1× larger
HCWB
$394.8K
$360.3K
CLW
Growing faster (revenue YoY)
CLW
CLW
+65.4% gap
CLW
-4.7%
-70.2%
HCWB
Higher net margin
CLW
CLW
850.9% more per $
CLW
-3.6%
-854.4%
HCWB
Faster 2-yr revenue CAGR
HCWB
HCWB
Annualised
HCWB
-45.8%
-96.8%
CLW

Income Statement — Q1 FY2026 vs Q4 FY2024

Metric
CLW
CLW
HCWB
HCWB
Revenue
$360.3K
$394.8K
Net Profit
$-12.8K
$-3.4M
Gross Margin
-0.2%
20.0%
Operating Margin
-795.9%
Net Margin
-3.6%
-854.4%
Revenue YoY
-4.7%
-70.2%
Net Profit YoY
-103.2%
68.4%
EPS (diluted)
$-10.47

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLW
CLW
HCWB
HCWB
Q1 26
$360.3K
Q4 25
$386.4M
Q3 25
$399.0M
Q2 25
$391.8M
Q1 25
$378.2M
Q4 24
$387.1M
$394.8K
Q3 24
$393.3M
$426.4K
Q2 24
$344.4M
$618.9K
Net Profit
CLW
CLW
HCWB
HCWB
Q1 26
$-12.8K
Q4 25
$38.3M
Q3 25
$-53.3M
Q2 25
$2.7M
Q1 25
$-6.3M
Q4 24
$199.1M
$-3.4M
Q3 24
$5.8M
$-3.9M
Q2 24
$-25.8M
$-15.3M
Gross Margin
CLW
CLW
HCWB
HCWB
Q1 26
-0.2%
Q4 25
4.5%
Q3 25
4.7%
Q2 25
11.0%
Q1 25
9.7%
Q4 24
3.8%
20.0%
Q3 24
7.7%
20.0%
Q2 24
-0.6%
29.2%
Operating Margin
CLW
CLW
HCWB
HCWB
Q1 26
Q4 25
1.9%
Q3 25
-13.9%
Q2 25
2.5%
Q1 25
-1.1%
Q4 24
-4.0%
-795.9%
Q3 24
-0.3%
-864.1%
Q2 24
-13.6%
-2445.8%
Net Margin
CLW
CLW
HCWB
HCWB
Q1 26
-3.6%
Q4 25
9.9%
Q3 25
-13.4%
Q2 25
0.7%
Q1 25
-1.7%
Q4 24
51.4%
-854.4%
Q3 24
1.5%
-915.1%
Q2 24
-7.5%
-2469.1%
EPS (diluted)
CLW
CLW
HCWB
HCWB
Q1 26
Q4 25
$2.36
Q3 25
$-3.30
Q2 25
$0.17
Q1 25
$-0.38
Q4 24
$11.87
$-10.47
Q3 24
$0.35
$-4.13
Q2 24
$-1.55
$-16.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLW
CLW
HCWB
HCWB
Cash + ST InvestmentsLiquidity on hand
$36.5M
$4.7M
Total DebtLower is stronger
$361.1M
$7.4M
Stockholders' EquityBook value
$813.8M
$-6.8M
Total Assets
$1.6B
$30.2M
Debt / EquityLower = less leverage
0.44×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLW
CLW
HCWB
HCWB
Q1 26
$36.5M
Q4 25
$30.7M
Q3 25
$34.4M
Q2 25
$46.7M
Q1 25
$44.0M
Q4 24
$79.6M
$4.7M
Q3 24
$35.5M
$998.2K
Q2 24
$39.6M
$1.2M
Total Debt
CLW
CLW
HCWB
HCWB
Q1 26
$361.1M
Q4 25
$346.8M
Q3 25
$337.0M
Q2 25
$330.1M
Q1 25
Q4 24
$283.4M
$7.4M
Q3 24
$1.2B
$6.5M
Q2 24
$1.1B
$9.9M
Stockholders' Equity
CLW
CLW
HCWB
HCWB
Q1 26
$813.8M
Q4 25
$825.3M
Q3 25
$783.0M
Q2 25
$836.8M
Q1 25
$836.6M
Q4 24
$854.6M
$-6.8M
Q3 24
$664.6M
$-10.0M
Q2 24
$658.6M
$-6.3M
Total Assets
CLW
CLW
HCWB
HCWB
Q1 26
$1.6B
Q4 25
$1.6B
Q3 25
$1.6B
Q2 25
$1.6B
Q1 25
$1.6B
Q4 24
$1.7B
$30.2M
Q3 24
$2.5B
$26.6M
Q2 24
$2.5B
$26.8M
Debt / Equity
CLW
CLW
HCWB
HCWB
Q1 26
0.44×
Q4 25
0.42×
Q3 25
0.43×
Q2 25
0.39×
Q1 25
Q4 24
0.33×
Q3 24
1.73×
Q2 24
1.74×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLW
CLW
HCWB
HCWB
Operating Cash FlowLast quarter
$-2.8M
Free Cash FlowOCF − Capex
$-2.9M
FCF MarginFCF / Revenue
-746.8%
Capex IntensityCapex / Revenue
28.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-14.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLW
CLW
HCWB
HCWB
Q1 26
Q4 25
$5.0M
Q3 25
$34.0M
Q2 25
$-28.2M
Q1 25
$1.5M
Q4 24
$-35.1M
$-2.8M
Q3 24
$16.2M
$-2.9M
Q2 24
$21.1M
$-4.9M
Free Cash Flow
CLW
CLW
HCWB
HCWB
Q1 26
Q4 25
$-9.9M
Q3 25
$15.7M
Q2 25
$-51.1M
Q1 25
$-31.2M
Q4 24
$-68.1M
$-2.9M
Q3 24
$-30.8M
$-3.0M
Q2 24
$3.0M
$-4.9M
FCF Margin
CLW
CLW
HCWB
HCWB
Q1 26
Q4 25
-2.6%
Q3 25
3.9%
Q2 25
-13.0%
Q1 25
-8.2%
Q4 24
-17.6%
-746.8%
Q3 24
-7.8%
-695.0%
Q2 24
0.9%
-788.7%
Capex Intensity
CLW
CLW
HCWB
HCWB
Q1 26
Q4 25
3.9%
Q3 25
4.6%
Q2 25
5.8%
Q1 25
8.6%
Q4 24
8.5%
28.7%
Q3 24
12.0%
8.7%
Q2 24
5.3%
3.0%
Cash Conversion
CLW
CLW
HCWB
HCWB
Q1 26
Q4 25
0.13×
Q3 25
Q2 25
-10.44×
Q1 25
Q4 24
-0.18×
Q3 24
2.79×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons